Integrin receptor-binding nanofibrous peptide hydrogel for combined mesenchymal stem cell therapy and nitric oxide delivery in renal ischemia/reperfusion injury

BACKGROUND: Mesenchymal-based therapy has been utilized as a practical approach in the treatment of renal ischemia/reperfusion (I/R) injury. However, low cell retention and survival in the ischemic site have remained challenging issues. To bridge this gap, the integrin receptor-binding RGD peptide-f...

Descripción completa

Detalles Bibliográficos
Autores principales: Najafi, Haniyeh, Abolmaali, Samira Sadat, Heidari, Reza, Valizadeh, Hadi, Tamaddon, Ali Mohammad, Azarpira, Negar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327234/
https://www.ncbi.nlm.nih.gov/pubmed/35883125
http://dx.doi.org/10.1186/s13287-022-03045-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327234/
https://www.ncbi.nlm.nih.gov/pubmed/35883125
http://dx.doi.org/10.1186/s13287-022-03045-1

Ejemplares similares